Abstract
The effect of humidity on the physicochemical properties of amorphous forms of cimetidine was investigated using differential scanning calorimetry, isothermal microcalorimetry, and x-ray diffraction analysis. Amorphous forms were obtained by the melting (amorphous form M [AM]) and the cotton candy (amorphous form C [AC]) methods. Thermal behaviors of AM and AC with or without seed crystals were measured using an isothermal microcalorimeter under various conditions of relative humidity (RH) and temperature, respectively. The crystallization kinetics of amorphous solids was analyzed based on 10 kinds of solid-state reaction models. AM transformed into form A at 11% RH, 50°C but transformed into a mixture of form A and monohydrate at 51% and 75% RH at 25°C. The mean crystallization times (MCTs) of the heat flow curve of AM and AC at 11% RH, 50°C were 47.82 and 32.00 hours, respectively, but at 11% RH, 25°C both were more than 4320 hours. In contrast, AC transformed into form A under all storage conditions. The MCTs of AC at 51% and 75% RH were 29.61 and 11.81 hours, respectively; whereas the MCTs of AM were 46.79 and 15.52 hours, respectively. The crystallization of amorphous solids followed the three-dimensional growth of nuclei (Avrami equation) with an induction period (IP). The IP for AM at 11% RH, 50°C was more than 2 times that for AC, but the difference in the crystal growth rate constant (CR) between AC and AM was within 10%. The IP for AM at 75% RH, 25°C was reduced to only 10% of the IP at 51% RH with increasing humidity, but the CR did not change significantly. In contrast, the IP for AC was slightly reduced at 75% RH compared with 51% RH, but the CR was about 5 times greater. At 75% RH, 25°C, the IP and CR of AM were about one-fourth the values of AC. This result suggests that the crystallization process consists of an initial stage during which the nuclei are formed and a final stage of growth.
Keywords: isothermal microcalorimetry, crystallization, amorphous, physicochemical stability, cimetidine
Full Text
The Full Text of this article is available as a PDF (754.4 KB).
References
- 1.Food and Drug Administration Guidelines: manufacturing and controls for INDs and NDAs. Pharm Tech Japan. 1985;1:835–850. [Google Scholar]
- 2.Haleblian JK. Characterization of habits and crystalline modification of solids and their pharmaceutical applications. J Pharm Sci. 1975;64:1269–1288. doi: 10.1002/jps.2600640805. [DOI] [PubMed] [Google Scholar]
- 3.Otsuka M, Matsuda Y. Polymorphism, pharmaceutical aspects. In: Swarbrick J, Boylan JC, editors. Encyclopedia of Pharmaceutical Technology. New York, NY: Marcel Dekker; 1995. pp. 305–326. [Google Scholar]
- 4.Briggner L, Buckton G, Bystrom K, Darcy P. The use of isothermal microcalorimetry in the study of changes in crystallinity induced during the processing of powders. Int J Pharm. 1994;105:125–135. doi: 10.1016/0378-5173(94)90458-8. [DOI] [Google Scholar]
- 5.Sebhatu T, Angberg M, Ahlneck C. Assessment of the degree of disorder in crystalline solids by isothermal microcalorimetry. Int J Pharm. 1994;104:135–144. doi: 10.1016/0378-5173(94)90188-0. [DOI] [Google Scholar]
- 6.Angberg M, Nyström C, Castensson S. Evaluation of heatconduction microcalorimetry in pharmaceutical stability studies, V: a new approach for continuous measurements in abundant water vapour. Int J Pharm. 1992;81:153–167. doi: 10.1016/0378-5173(92)90007-O. [DOI] [Google Scholar]
- 7.Sheridan PL, Buckton G, Storey DE. Development of a flow microcalorimetry method for the assessment of surface properties of powders. Pharm Res. 1995;12:1025–1030. doi: 10.1023/A:1016262531972. [DOI] [PubMed] [Google Scholar]
- 8.Buckton G, Darcy P, Greenleaf D, Holbrook P. The use of isothermal microcalorimetry in the study of changes in crystallinity of spraydried salbutamol sulphate. Int J Pharm. 1995;116:113–118. doi: 10.1016/0378-5173(94)00322-V. [DOI] [Google Scholar]
- 9.Aso Y, Yoshioka S, Otsuka T, Kojima S. The physical stability of amorphous nifedipine determined by isothermal microcalorimetry. Chem Pharm Bull. 1995;43:300–303. [Google Scholar]
- 10.Rat M, Guillaume P, Wilker S, Pantel G. Practical application of microcalorimetry to the stability of propellants. Sevenoaks, UK: Defence Research Agency; 1997. pp. V1–V18. [Google Scholar]
- 11.Mimura H, Kitamura S, Koda S. Evaluation of drug stability by isothermal microcalorimetry. Netsu Sokutei. 1998;25(4):92–96. [Google Scholar]
- 12.Giron D. Thermal analysis, microcalorimetry and combined techniques for the study of pharmaceuticals. J Therm Anal Calorim. 1999;56(3):1285–1304. doi: 10.1023/A:1010194020563. [DOI] [Google Scholar]
- 13.Du W, Li X, Wang B, Zhang Y. A study on the interaction between cisplatin and urease. Thermochim Acta. 1999;333(2):109–114. doi: 10.1016/S0040-6031(99)00115-X. [DOI] [Google Scholar]
- 14.Beezer A, Gaisford S, Hills AK, Mitchell JC. Pharmaceutical microcalorimetry: applications to long-term stability studies. Int J Pharm. 1999;179(2):159–165. doi: 10.1016/S0378-5173(98)00336-6. [DOI] [PubMed] [Google Scholar]
- 15.Runge FE, Heger R. Use of microcalorimetry in monitoring stability. Example: vitamin A esters. J Agric Food Chem. 2000;48(1):47–55. doi: 10.1021/jf981163y. [DOI] [PubMed] [Google Scholar]
- 16.Tompa AS, Bryant WF. Microcalorimetry and DSC study of the compatibility of energetic materials. Sevenoaks, UK: Defence Research Agency; 1999. pp. Q1–Q21. [Google Scholar]
- 17.Phipps MA, Mackin LA. Application of isothermal calorimetry in solid state drug development. Pharm Sci Technol Today. 2000;3(1):9–17. doi: 10.1016/S1461-5347(99)00227-8. [DOI] [PubMed] [Google Scholar]
- 18.Shibata M, Kokubo H, Morimoto K, Morisaka K, Ishida T, Inoue M. X-ray structural studies and physicochemical properties of cimetidine polymorphism. J Pharm Sci. 1983;72:1436–1442. doi: 10.1002/jps.2600721217. [DOI] [PubMed] [Google Scholar]
- 19.Hegedüs B, Görög S. The polymorphism of cimetidine. J Pharm Biomed Anal. 1985;3:303–313. doi: 10.1016/0731-7085(85)80037-6. [DOI] [PubMed] [Google Scholar]
- 20.Hancock JD, Sharp JH. Method of comparing solid-state kinetic data and its application to the decomposition of kaolinite, brucite, and BaCO3. J Am Ceram Soc. 1972;55:74–77. doi: 10.1111/j.1151-2916.1972.tb11213.x. [DOI] [Google Scholar]
- 21.Otsuka M, Kaneniwa N. Dehydration of cephalexin hydrates. Chem Pharm Bull. 1983;31:1021–1029. [Google Scholar]
- 22.Tanigawara Y, Yamakoka K, Nakagawa T, Uno T. Moment analysis for the separation of mean in vivo disintegration, dissolution, absorption, and disposition time of ampicillin products. J Pharm Sci. 1982;71(10):1129–1133. doi: 10.1002/jps.2600711013. [DOI] [PubMed] [Google Scholar]